FDA Grants Approval for Pantoprazole Sodium ANDA219973
The FDA has granted approval for ANDA219973, a generic version of Pantoprazole Sodium, submitted by Shuangcheng.
Asset / Drug
Drug and asset intelligence for Shuangcheng with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Proton Pump Inhibitor
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.